EIF3H - eukaryotic translation initiation factor 3 subunit H Gene

中文名称：真核翻译起始因子 3 亚基 H

种属: Homo sapiens

同用名: EIF3S3; eIF3-p40; eIF3-gamma

基因 ID: 8667 | 基因类型: protein coding

关于 EIF3H

Cytogenetic location: 8q23.3-q24.11 Genomic coordinates (GRCh38): 8:116,642,130-116,766,374 (from NCBI)

This gene has 11 transcripts (splice variants), 220 orthologues and 3 paralogues. Ubiquitous expression in ovary (RPKM 170.8), thyroid (RPKM 126.9) and 25 other tissues.

功能概要

启用去泛素化酶活性。有助于翻译起始因子活动。参与蛋白酶体泛素依赖性蛋白质分解代谢过程和翻译起始的负调控。位于细胞外外泌体和细胞膜。真核翻译起始因子 3 复合体的一部分。与乳腺癌有关；前列腺癌;和前列腺癌。前列腺癌的生物标志物。 [由基因组资源联盟提供，2022 年 4 月]

Enables Deubiquitinase activity. Contributes to translation initiation factor activity. Involved in negative regulation of proteasomal ubiquitin-dependent protein catabolic process and translational initiation. Located in extracellular exosome and membrane. Part of eukaryotic translation initiation factor 3 complex. Implicated in breast cancer; prostate cancer; and prostate carcinoma. Biomarker of prostate Cancer. [provided by Alliance of Genome Resources, Apr 2022]

EIF3H 基因产物(1)

mRNA	Protein	Name
NM_003756.3	NP_003747.1	eukaryotic translation initiation factor 3 subunit H

基因本体论

分子功能
生物过程
细胞组分

分子功能 GO 注释	逻辑证据	参考文献	来源
enables metal-dependent deubiquitinase activity	IDA IDA: 通过直接分析推断	32269044	GOA
enables protein binding	IPI IPI: 通过物理相互作用推断	12812986	GOA
contributes to translation initiation factor activity	IDA IDA: 通过直接分析推断	17581632	GOA

生物过程 GO 注释	逻辑证据	参考文献	来源
involved in negative regulation of proteasomal ubiquitin-dependent protein catabolic process	IDA IDA: 通过直接分析推断	32269044	GOA
involved in translational initiation	IDA IDA: 通过直接分析推断	17581632	GOA

细胞组分 GO 注释	逻辑证据	参考文献	来源
part of eukaryotic translation initiation factor 3 complex	IDA IDA: 通过直接分析推断	17322308	GOA
part of eukaryotic translation initiation factor 3 complex	IPI IPI: 通过物理相互作用推断	17322308	GOA

EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

EIF3H 蛋白结构

JAB

0
100
200
300
352 a.a.

蛋白主名

其他名称

eukaryotic translation initiation factor 3 subunit H

eIF-3-gamma

EIF3H 蛋白互作信息

分类	蛋白名称	蛋白编号	互作蛋白	互作蛋白种属	互作蛋白编号	实验方法	参考文献
种属内	EIF3H	O15372	ABI1	Homo sapiens	Q8IZP0-5	Validated Y2H	32296183
种属内	EIF3H	O15372	ABI1	Homo sapiens	Q8IZP0-5	Y2H Prey Pooling	32296183
种属内	EIF3H	O15372	ABI1	Homo sapiens	Q8IZP0-5	Y2H Array	32296183
种属内	EIF3H	O15372	SORBS2	Homo sapiens	O94875-10	Validated Y2H	32296183
种属内	EIF3H	O15372	DISC1	Homo sapiens	Q9NRI5-1	Y2H	17043677
种属内	EIF3H	O15372	EIF3M	Homo sapiens	Q7L2H7	Anti Tag CoIP	18599441
种属内	EIF3H	O15372	EIF3M	Homo sapiens	Q7L2H7	Anti Tag CoIP	33961781
种属内	EIF3H	O15372	EIF3M	Homo sapiens	Q7L2H7	Anti Tag CoIP	28514442
种属内	EIF3H	O15372	EIF3M	Homo sapiens	Q7L2H7	SLCA	18599441
种属内	EIF3H	O15372	EIF3M	Homo sapiens	Q7L2H7	Anti Tag CoIP	19615732
种属内	EIF3H	O15372	EIF3M	Homo sapiens	Q7L2H7	Pull Down	23623729
种属内	EIF3H	O15372	EIF3B	Homo sapiens	P55884	Anti Tag CoIP	19615732
种属内	EIF3H	O15372	EIF3B	Homo sapiens	P55884	Anti Tag CoIP	33961781
种属内	EIF3H	O15372	DISC1	Homo sapiens	Q9NRI5	Y2H	12812986
种属内	EIF3H	O15372	EIF3F	Homo sapiens	O00303	Anti Tag CoIP	18599441
种属内	EIF3H	O15372	EIF3F	Homo sapiens	O00303	Pull Down	23623729
种属内	EIF3H	O15372	NCK2	Homo sapiens	O43639	Y2H Prey Pooling	32296183
种属内	EIF3H	O15372	NCK2	Homo sapiens	O43639	Validated Y2H	32296183
种属内	EIF3H	O15372	NCK2	Homo sapiens	O43639	Y2H Array	32296183
种属内	EIF3H	O15372	SORBS3	Homo sapiens	O60504	Validated Y2H	32296183
种属内	EIF3H	O15372	SORBS3	Homo sapiens	O60504	Y2H Prey Pooling	32296183
种属内	EIF3H	O15372	SORBS3	Homo sapiens	O60504	Y2H Array	32296183
种属内	EIF3H	O15372	ABI3	Homo sapiens	Q9P2A4	Y2H Pooling	16189514
种属内	EIF3H	O15372	ABI3	Homo sapiens	Q9P2A4	Validated Y2H	32296183
种属内	EIF3H	O15372	EIF3CL	Homo sapiens	B5ME19	Anti Tag CoIP	33961781
种属内	EIF3H	O15372	EIF3CL	Homo sapiens	B5ME19	Anti Tag CoIP	28514442

种属间: 跨种属相互作用 种属内: 同种属相互作用

关联疾病

疾病名称

别名

Prostate Cancer

Prostate Carcinoma	Prostate Cancer, Familial
Prostate Neoplasm	Prostate Cancer, Somatic
Prostate Cancer, Susceptibility To	Prostatic Cancer
Prostatic Neoplasms	Hereditary Prostate Cancer
Prostatic Neoplasm	Cancer Of Prostate
Carcinoma Of Prostate	Familial Prostate Cancer
Familial Prostate Carcinoma	Malignant Tumor Of Prostate
Malignant Neoplasm Of Prostate	Prostate Cancer, Familial, Susceptibility To
Malignant Tumor Of The Prostate	Ngp - New Growth Of Prostate
Tumor Of The Prostate	Prostate Cancer, Hereditary
Cancer Of The Prostate	Malignant Neoplasm Of The Prostate
Prostatic Carcinoma	PC
Prca	Cancer, Prostate
Malignant Prostatic Tumour	Malignant Tumour Of Prostate
Primary Prostate Cancer	Primary Malignant Neoplasm Of Prostate
Prostate Gland Cancer

Trichorhinophalangeal Syndrome, Type Ii

Langer-Giedion Syndrome	Lgs
Trichorhinophalangeal Syndrome Type Ii	Trichorhinophalangeal Syndrome Type 2
TRPS2	Monosomy 8q24.1
Chromosome 8q24.1 Deletion Syndrome	Deletion 8q24.1
Giedion-Langer Syndrome	Trichorhinophalangeal Dysplasia Type Ii
Langer Giedion Syndrome	Trps 2
Tricho-Rhino-Phalangeal Syndrome Type Ii	Trichorhinophalangeal Syndrome With Exostosis
Trps Ii	Tricho-Rhino-Phalangeal Syndrome 2
8q24.1 Microdeletion Syndrome	8q24.1 Deletion Syndrome

Breast Cancer

Breast Carcinoma	Male Breast Cancer
Breast Cancer, Familial	Malignant Neoplasm Of Breast
Breast Cancer, Susceptibility To	Breast Cancer, Early-Onset
Malignant Tumor Of Breast	Carcinoma Of Male Breast
Breast Cancer, Invasive Ductal	Breast Cancer, Protection Against
Breast Cancer, Somatic	Breast Cancer, Male
Breast Cancer, Lobular, Somatic	Breast Tumor
Mammary Cancer	Mammary Tumor
Malignant Neoplasm Of Male Breast	Mammary Carcinoma
Male Breast Carcinoma	Familial Cancer Of Breast
Invasive Ductal Breast Carcinoma	Breast Cancer Susceptibility
Breast Cancer, Male, Susceptibility To	Breast Cancer, Early-Onset, Susceptibility To
Malignant Tumor Of The Breast	Mammary Neoplasm
Primary Breast Cancer	Neoplasm Of Male Breast
Carcinoma Of Breast	Breast Cancer In Men
Familial Breast Cancer	Cancer Of Breast
BC	Breast Cancer Familial
Breast Cancer Familial Male	Breast Cancer, Familial Male
Breast Male Carcinoma	Breast Neoplasms
Breast Neoplasms, Male	Mammary Tumors
Mammary Carcinomas	Cancer, Breast
Cancer, Breast, Susceptibility	Invasive Breast Ductal Carcinoma
Breast Neoplasm	Susceptibility To Breast Cancer
Mammary Neoplasms	Animal Mammary Neoplasms
Primary Malignant Neoplasm Of Breast	Infiltrating Ductal Carcinoma Of Breast
Infiltrating Duct Carcinoma Of Unspecified Site	Infiltrating Ductular Carcinoma Of Unspecified Site
Invasive Breast Carcinoma Of No Special Type	Microinvasive Carcinoma Of Breast
Carcinoma With Apocrine Differentiation

疾病名称	别名
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Cat. No.	产品名	作用方式	纯度	是否罕见病
HY-RS04264	EIF3H Human Pre-designed siRNA Set A	Pre-designed Sets	/	否

直系同源

种属	基因名	来源	基因 ID
Rattus norvegicus	EIF3H	RGD	RGD:735178
Felis catus	EIF3H	VGNC	VGNC:81651
Mus musculus	EIF3H	MGD	MGI:1915385
Macaca mulatta	EIF3H	VGNC	VGNC:72189
Bos taurus	EIF3H	VGNC	VGNC:28398
Canis familiaris	EIF3H	VGNC	VGNC:40274

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4